ArriVent BioPharma Inc. (AVBP)
NASDAQ: AVBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 7, 3:28 PM ET
AVBP stock chart
Technical analysisKey statistics
All statistics- Market cap
- $832.32M
- EPS (TTM)
- -$3.62
- Dividend yield
- None
- 52-week range
- 11.36 – 35.83
- Day range
- 14.97 – 17.35
- Volume / Avg
- 3.05M / 827.30K
- Beta
- —
- Shares outstanding
- 49.31M
- Next earnings
- Nov 16, 2026
52-week range
AVBP stock today
On Oct 7, AVBP is trading at $16.88, adding $1.79 (11.86%), versus the S&P 500's 0.25% decline. Volume was 3.7x the average at 3.05M shares, a sign of unusually heavy trading. Shares are 52.9% below their 52-week high of $35.83 and 48.6% above the 52-week low of $11.36, in the middle of the past year's range.
ArriVent BioPharma has posted a net loss over the last twelve months (EPS of -$3.62), so its P/E ratio is not meaningful. ArriVent BioPharma's next earnings report is expected on Nov 16, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About ArriVent BioPharma
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2024
Earnings
Earnings history- Next report
- Nov 16, 2026
AVBP news
All AVBP newsArriVent BioPharma peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GYREGyre Therapeutics Inc. | 7.03 | -0.71% | $745.42M | vs AVBP |
| APMDApnimed Inc. | 17.92 | -3.91% | $746.02M | vs AVBP |
| AVTXAvalo Therapeutics Inc. | 13.66 | +0.48% | $732.32M | vs AVBP |
| VSTMVerastem Inc. | 8.35 | +7.74% | $756.20M | vs AVBP |
| DSGNDesign Therapeutics Inc. | 11.64 | -2.76% | $728.45M | vs AVBP |
| ANNXAnnexon Inc. | 4.05 | +0.37% | $766.85M | vs AVBP |
| GERNGeron Corporation | 1.20 | -1.24% | $767.76M | vs AVBP |
| HELPHelus Pharma Inc. | 10.56 | -1.86% | $771.52M | vs AVBP |
Indexes, lists and sector
Largest Health Care stocks
ArriVent BioPharma stock FAQ
What is ArriVent BioPharma's stock price today?
AVBP last traded at $16.88 as of Oct 7, 3:28 PM EDT, up 11.86% on the day. Prices are delayed at least 15 minutes.
When is ArriVent BioPharma's next earnings date?
ArriVent BioPharma is expected to report earnings on Monday, November 16, 2026.
What is the AVBP 52-week high?
The 52-week high for AVBP is $35.83 and the 52-week low is $11.36. The stock is currently 52.9% below its high.